Skip to main content
Yue Yuan, Weinberg Distinguished Staff Fellow at ORNL, is researching ways to create new materials to help the environment. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy

Growing up in China, Yue Yuan stood beneath the world’s largest hydroelectric dam, built to harness the world’s third-longest river. Her father brought her to Three Gorges Dam every year as it was being constructed across the Yangtze River so she could witness its progress.

An AI-generated image representing atoms and artificial neural networks. Credit: Maxim Ziatdinov, ORNL

Researchers at ORNL have developed a machine-learning inspired software package that provides end-to-end image analysis of electron and scanning probe microscopy images.

Artificial intelligence is becoming an increasingly valuable tool for ORNL researchers tackling the many mysteries of cancer. Credit: Getty Images.

A team of researchers from ORNL was recognized by the National Cancer Institute in March for their unique contributions in the fight against cancer.

The licensing and leadership team behind AMIGO. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

A technology developed at ORNL and used by the U.S. Naval Information Warfare Systems Command, or NAVWAR, to test the capabilities of commercial security tools has been licensed to cybersecurity firm Penguin Mustache to create its Evasive.ai platform. The company was founded by the technology’s creator, former ORNL scientist Jared M. Smith, and his business partner, entrepreneur Brandon Bruce.

Samantha Peters co-designed and conducted experiments using ORNL’s high-performance mass spectrometry techniques to prove that bacteriophages deploy genetic code-switching to overwhelm and destroy host bacteria. Credit: Genevieve Martin, ORNL/U.S. Dept. of Energy

Scientists at ORNL have confirmed that bacteria-killing viruses called bacteriophages deploy a sneaky tactic when targeting their hosts: They use a standard genetic code when invading bacteria, then switch to an alternate code at later stages of

A new license to U2opia pairs two technologies developed in ORNL’s Cyber Resilience and Intelligence Division: Situ and Heartbeat. Credit: ORNL, U.S. Dept. of Energy

U2opia Technology, a consortium of technology and administrative executives with extensive experience in both industry and defense, has exclusively licensed two technologies from ORNL that offer a new method for advanced cybersecurity monitoring in real time.

When an electron beam drills holes in heated graphene, single-atom vacancies, shown in purple, diffuse until they join with other vacancies to form stationary structures and chains, shown in blue. Credit: Ondrej Dyck/ORNL, U.S. Dept. of Energy

Oak Ridge National Laboratory researchers serendipitously discovered when they automated the beam of an electron microscope to precisely drill holes in the atomically thin lattice of graphene, the drilled holes closed up.

A pure lipid membrane formed using lipid-coated water droplets exhibits long-term potentiation, or LTP, associated with learning and memory, emulating hippocampal LTP observed in the brains of mammals and birds. Credit: Jill Hemman/ORNL, U.S. Dept. of Energy

While studying how bio-inspired materials might inform the design of next-generation computers, scientists at ORNL achieved a first-of-its-kind result that could have big implications for both edge computing and human health.

Eight ORNL scientists are among the world’s most highly cited researchers, Credit: Butch Newton/ORNL, U.S. Dept. of Energy

Eight ORNL scientists are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.

ORNL researchers led by Michael Garvin, left, and David Kainer discovered genetic mutations called structural variants and linked them to autism spectrum disorders, demonstrating an approach that could be used to develop better diagnostics and drug therapies. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

ORNL researchers discovered genetic mutations that underlie autism using a new approach that could lead to better diagnostics and drug therapies.